Peroxisome Targeting Signal Binding — Obsoletion & Replacement

SCOPING OBSOLETION

Warnings (1)

Peroxisome Targeting Signal Binding — Obsoletion & Replacement

Overview

A GO obsoletion proposal will collapse three sibling "targeting signal binding"
terms into their parent (renamed to a receptor activity term). The rationale is
that these distinct signal sequences are recognized by the same receptor in each
case, so the precise sequence type is beyond GO's scope.

This project tracks the impact on AI Gene Review reviews and queues the affected
gene reviews for refresh once the obsoletion lands.

Upstream tickets

Obsoletion plan (per upstream)

Three terms to be obsoleted, replaced by their (renamed) parent:

Obsoleted term ID Replacement
peroxisome matrix targeting signal-1 binding GO:0005052 parent of "peroxisome targeting sequence binding", to be renamed "peroxisome signal sequence receptor activity"
peroxisome matrix targeting signal-2 binding GO:0005053 same parent
peroxisome membrane targeting sequence binding GO:0033328 same parent

Affected upstream annotations (from issue body): 45 total — AspGD 2, ComplexPortal 2,
GeneDB 1, SGD 5, UniProt 30, UniProt-extensions 5. Plus an InterPro mapping
IPR044536 → GO:0005053 that will need to be redirected.

Impact on this repo

The obsoleted terms appear in three already-reviewed human genes (existing
existing_annotations entries that will need refresh once the obsoletion lands):

Gene UniProt File Affected term(s) Notes
PEX5 P50542 genes/human/PEX5/PEX5-ai-review.yaml GO:0005052 (multiple IDA, IBA), GO:0033328 (IPI) PTS1 receptor; multiple IDA-supported entries
PEX7 O00628 genes/human/PEX7/PEX7-ai-review.yaml GO:0005053 (IDA, IBA, IEA from InterPro IPR044536) PTS2 receptor; receives the InterPro2GO mapping that also needs redirection
PEX19 P40855 genes/human/PEX19/PEX19-ai-review.yaml GO:0033328 (IBA) Cytosolic PMP receptor/chaperone

These genes are already part of the broader PEROXISOME project.

Scope

Candidate genes for refresh (once obsoletion lands)

Initial set — genes already reviewed in this repo whose annotations cite one of
the three to-be-obsoleted terms:

  1. PEX5 (human) — PTS1 receptor; primary affected gene with both GO:0005052 and GO:0033328 annotations.
  2. PEX7 (human) — PTS2 receptor; affected by GO:0005053 obsoletion and the IPR044536 → GO:0005053 mapping.
  3. PEX19 (human) — Cytosolic PMP receptor; affected by GO:0033328 obsoletion.

Additional candidates to consider once the obsoletion is applied (not yet in
this repo, but flagged by the upstream tally — do not add without verifying via
just fetch-gene):

  1. SGD: Pex5p/Pex7p/Pex19p (S. cerevisiae orthologs) — the issue lists 5 SGD annotations.
  2. AspGD: Aspergillus PEX5/PEX7 orthologs — 2 annotations.
  3. GeneDB / ComplexPortal entries referenced by the upstream spreadsheet.

Proposed approach

  1. Wait for obsoletion to land. The decision is not yet final — comment
    thread on go-ontology#31419 should be monitored. Do not pre-emptively edit
    reviews against terms that may still survive.
  2. After obsoletion, regenerate GOA files for PEX5, PEX7, PEX19 with
    just fetch-gene human <gene>; the merged parent term should appear in
    place of the obsoleted children.
  3. Re-review the affected existing_annotations entries. The biological
    conclusion should not change (the receptors still bind their cognate
    signals), but action codes may need updating where reviews previously
    accepted the more specific child term as core function. Consider whether
    the renamed parent ("peroxisome signal sequence receptor activity") is an
    appropriate ACCEPT for core_functions, or whether a more informative MF
    term should be proposed.
  4. InterPro2GO mapping — flag for upstream that IPR044536 will need
    redirection to the merged parent (this is upstream's responsibility, not
    ours, but worth noting in PEX7 review).
  5. Decide on yeast/Aspergillus orthologs. If the broader peroxisome
    project expands beyond human, add SGD/AspGD orthologs at that point rather
    than as part of this obsoletion-tracking work.

Priority

Low/medium — passive tracking until the obsoletion is approved and applied.
The biology of the affected reviews is well-characterized and the change is
mechanical (term ID/label refresh) rather than scientific.

Status